A study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24–<48 months of age
- 1 January 2020
- Vol. 38 (5) , 1001-1008
Abstract
No abstract availableKeywords
Funding Information
- MedImmune
This publication has 18 references indexed in Scilit:
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza SeasonMMWR. Recommendations and Reports, 2017
- Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015–2016: A Systematic Review and Meta-AnalysisOpen Forum Infectious Diseases, 2017
- Prevention and Control of Seasonal Influenza with VaccinesMMWR. Recommendations and Reports, 2016
- Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza SeasonMMWR. Morbidity and Mortality Weekly Report, 2015
- Development of live attenuated influenza vaccines against pandemic influenza strainsExpert Review of Vaccines, 2014
- Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interferenceExpert Review of Vaccines, 2011
- Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6–59 months of ageVaccine, 2011
- Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of ageVaccine, 2008
- Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in AsiaThe Pediatric Infectious Disease Journal, 2007
- Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day CarePediatrics, 2006